Cargando…

Alterations in white matter fiber density associated with structural MRI and metabolic PET lesions following multimodal therapy in glioma patients

BACKGROUND: In glioma patients, multimodality therapy and recurrent tumor can lead to structural brain tissue damage characterized by pathologic findings in MR and PET imaging. However, little is known about the impact of different types of damage on the fiber architecture of the affected white matt...

Descripción completa

Detalles Bibliográficos
Autores principales: Friedrich, Michel, Farrher, Ezequiel, Caspers, Svenja, Lohmann, Philipp, Lerche, Christoph, Stoffels, Gabriele, Filss, Christian P., Weiss Lucas, Carolin, Ruge, Maximilian I., Langen, Karl-Josef, Shah, Nadim J., Fink, Gereon R., Galldiks, Norbert, Kocher, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702073/
https://www.ncbi.nlm.nih.gov/pubmed/36452509
http://dx.doi.org/10.3389/fonc.2022.998069
_version_ 1784839654303858688
author Friedrich, Michel
Farrher, Ezequiel
Caspers, Svenja
Lohmann, Philipp
Lerche, Christoph
Stoffels, Gabriele
Filss, Christian P.
Weiss Lucas, Carolin
Ruge, Maximilian I.
Langen, Karl-Josef
Shah, Nadim J.
Fink, Gereon R.
Galldiks, Norbert
Kocher, Martin
author_facet Friedrich, Michel
Farrher, Ezequiel
Caspers, Svenja
Lohmann, Philipp
Lerche, Christoph
Stoffels, Gabriele
Filss, Christian P.
Weiss Lucas, Carolin
Ruge, Maximilian I.
Langen, Karl-Josef
Shah, Nadim J.
Fink, Gereon R.
Galldiks, Norbert
Kocher, Martin
author_sort Friedrich, Michel
collection PubMed
description BACKGROUND: In glioma patients, multimodality therapy and recurrent tumor can lead to structural brain tissue damage characterized by pathologic findings in MR and PET imaging. However, little is known about the impact of different types of damage on the fiber architecture of the affected white matter. PATIENTS AND METHODS: This study included 121 pretreated patients (median age, 52 years; ECOG performance score, 0 in 48%, 1-2 in 51%) with histomolecularly characterized glioma (WHO grade IV glioblastoma, n=81; WHO grade III anaplastic astrocytoma, n=28; WHO grade III anaplastic oligodendroglioma, n=12), who had a resection, radiotherapy, alkylating chemotherapy, or combinations thereof. After a median follow-up time of 14 months (range, 1-214 months), anatomic MR and O-(2-[(18)F]fluoroethyl)-L-tyrosine (FET) PET images were acquired on a 3T hybrid PET/MR scanner. Post-therapeutic findings comprised resection cavities, regions with contrast enhancement or increased FET uptake and T2/FLAIR hyperintensities. Local fiber density was determined from high angular-resolution diffusion-weighted imaging and advanced tractography methods. A cohort of 121 healthy subjects selected from the 1000BRAINS study matched for age, gender and education served as a control group. RESULTS: Lesion types differed in both affected tissue volumes and relative fiber densities compared to control values (resection cavities: median volume 20.9 mL, fiber density 16% of controls; contrast-enhanced lesions: 7.9 mL, 43%; FET uptake areas: 30.3 mL, 49%; T2/FLAIR hyperintensities: 53.4 mL, 57%, p<0.001). In T2/FLAIR-hyperintense lesions caused by peritumoral edema due to recurrent glioma (n=27), relative fiber density was as low as in lesions associated with radiation-induced gliosis (n=13, 48% vs. 53%, p=0.17). In regions with pathologically increased FET uptake, local fiber density was inversely related (p=0.005) to the extent of uptake. Total fiber loss associated with contrast-enhanced lesions (p=0.006) and T2/FLAIR hyperintense lesions (p=0.013) had a significant impact on overall ECOG score. CONCLUSIONS: These results suggest that apart from resection cavities, reduction in local fiber density is greatest in contrast-enhancing recurrent tumors, but total fiber loss induced by edema or gliosis has an equal detrimental effect on the patients’ performance status due to the larger volume affected.
format Online
Article
Text
id pubmed-9702073
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97020732022-11-29 Alterations in white matter fiber density associated with structural MRI and metabolic PET lesions following multimodal therapy in glioma patients Friedrich, Michel Farrher, Ezequiel Caspers, Svenja Lohmann, Philipp Lerche, Christoph Stoffels, Gabriele Filss, Christian P. Weiss Lucas, Carolin Ruge, Maximilian I. Langen, Karl-Josef Shah, Nadim J. Fink, Gereon R. Galldiks, Norbert Kocher, Martin Front Oncol Oncology BACKGROUND: In glioma patients, multimodality therapy and recurrent tumor can lead to structural brain tissue damage characterized by pathologic findings in MR and PET imaging. However, little is known about the impact of different types of damage on the fiber architecture of the affected white matter. PATIENTS AND METHODS: This study included 121 pretreated patients (median age, 52 years; ECOG performance score, 0 in 48%, 1-2 in 51%) with histomolecularly characterized glioma (WHO grade IV glioblastoma, n=81; WHO grade III anaplastic astrocytoma, n=28; WHO grade III anaplastic oligodendroglioma, n=12), who had a resection, radiotherapy, alkylating chemotherapy, or combinations thereof. After a median follow-up time of 14 months (range, 1-214 months), anatomic MR and O-(2-[(18)F]fluoroethyl)-L-tyrosine (FET) PET images were acquired on a 3T hybrid PET/MR scanner. Post-therapeutic findings comprised resection cavities, regions with contrast enhancement or increased FET uptake and T2/FLAIR hyperintensities. Local fiber density was determined from high angular-resolution diffusion-weighted imaging and advanced tractography methods. A cohort of 121 healthy subjects selected from the 1000BRAINS study matched for age, gender and education served as a control group. RESULTS: Lesion types differed in both affected tissue volumes and relative fiber densities compared to control values (resection cavities: median volume 20.9 mL, fiber density 16% of controls; contrast-enhanced lesions: 7.9 mL, 43%; FET uptake areas: 30.3 mL, 49%; T2/FLAIR hyperintensities: 53.4 mL, 57%, p<0.001). In T2/FLAIR-hyperintense lesions caused by peritumoral edema due to recurrent glioma (n=27), relative fiber density was as low as in lesions associated with radiation-induced gliosis (n=13, 48% vs. 53%, p=0.17). In regions with pathologically increased FET uptake, local fiber density was inversely related (p=0.005) to the extent of uptake. Total fiber loss associated with contrast-enhanced lesions (p=0.006) and T2/FLAIR hyperintense lesions (p=0.013) had a significant impact on overall ECOG score. CONCLUSIONS: These results suggest that apart from resection cavities, reduction in local fiber density is greatest in contrast-enhancing recurrent tumors, but total fiber loss induced by edema or gliosis has an equal detrimental effect on the patients’ performance status due to the larger volume affected. Frontiers Media S.A. 2022-11-14 /pmc/articles/PMC9702073/ /pubmed/36452509 http://dx.doi.org/10.3389/fonc.2022.998069 Text en Copyright © 2022 Friedrich, Farrher, Caspers, Lohmann, Lerche, Stoffels, Filss, Weiss Lucas, Ruge, Langen, Shah, Fink, Galldiks and Kocher https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Friedrich, Michel
Farrher, Ezequiel
Caspers, Svenja
Lohmann, Philipp
Lerche, Christoph
Stoffels, Gabriele
Filss, Christian P.
Weiss Lucas, Carolin
Ruge, Maximilian I.
Langen, Karl-Josef
Shah, Nadim J.
Fink, Gereon R.
Galldiks, Norbert
Kocher, Martin
Alterations in white matter fiber density associated with structural MRI and metabolic PET lesions following multimodal therapy in glioma patients
title Alterations in white matter fiber density associated with structural MRI and metabolic PET lesions following multimodal therapy in glioma patients
title_full Alterations in white matter fiber density associated with structural MRI and metabolic PET lesions following multimodal therapy in glioma patients
title_fullStr Alterations in white matter fiber density associated with structural MRI and metabolic PET lesions following multimodal therapy in glioma patients
title_full_unstemmed Alterations in white matter fiber density associated with structural MRI and metabolic PET lesions following multimodal therapy in glioma patients
title_short Alterations in white matter fiber density associated with structural MRI and metabolic PET lesions following multimodal therapy in glioma patients
title_sort alterations in white matter fiber density associated with structural mri and metabolic pet lesions following multimodal therapy in glioma patients
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702073/
https://www.ncbi.nlm.nih.gov/pubmed/36452509
http://dx.doi.org/10.3389/fonc.2022.998069
work_keys_str_mv AT friedrichmichel alterationsinwhitematterfiberdensityassociatedwithstructuralmriandmetabolicpetlesionsfollowingmultimodaltherapyingliomapatients
AT farrherezequiel alterationsinwhitematterfiberdensityassociatedwithstructuralmriandmetabolicpetlesionsfollowingmultimodaltherapyingliomapatients
AT casperssvenja alterationsinwhitematterfiberdensityassociatedwithstructuralmriandmetabolicpetlesionsfollowingmultimodaltherapyingliomapatients
AT lohmannphilipp alterationsinwhitematterfiberdensityassociatedwithstructuralmriandmetabolicpetlesionsfollowingmultimodaltherapyingliomapatients
AT lerchechristoph alterationsinwhitematterfiberdensityassociatedwithstructuralmriandmetabolicpetlesionsfollowingmultimodaltherapyingliomapatients
AT stoffelsgabriele alterationsinwhitematterfiberdensityassociatedwithstructuralmriandmetabolicpetlesionsfollowingmultimodaltherapyingliomapatients
AT filsschristianp alterationsinwhitematterfiberdensityassociatedwithstructuralmriandmetabolicpetlesionsfollowingmultimodaltherapyingliomapatients
AT weisslucascarolin alterationsinwhitematterfiberdensityassociatedwithstructuralmriandmetabolicpetlesionsfollowingmultimodaltherapyingliomapatients
AT rugemaximiliani alterationsinwhitematterfiberdensityassociatedwithstructuralmriandmetabolicpetlesionsfollowingmultimodaltherapyingliomapatients
AT langenkarljosef alterationsinwhitematterfiberdensityassociatedwithstructuralmriandmetabolicpetlesionsfollowingmultimodaltherapyingliomapatients
AT shahnadimj alterationsinwhitematterfiberdensityassociatedwithstructuralmriandmetabolicpetlesionsfollowingmultimodaltherapyingliomapatients
AT finkgereonr alterationsinwhitematterfiberdensityassociatedwithstructuralmriandmetabolicpetlesionsfollowingmultimodaltherapyingliomapatients
AT galldiksnorbert alterationsinwhitematterfiberdensityassociatedwithstructuralmriandmetabolicpetlesionsfollowingmultimodaltherapyingliomapatients
AT kochermartin alterationsinwhitematterfiberdensityassociatedwithstructuralmriandmetabolicpetlesionsfollowingmultimodaltherapyingliomapatients